Safety and Usability of the ATLAS 2030 Robotic Gait Device in Children
Author Information
Author(s): Cumplido-Trasmonte Carlos, Barquín-Santos Eva, Aneiros-Tarancón Fernando, Plaza-Flores Alberto, Espinosa-García Sandra, Fernández Roemi, García-Armada Elena
Primary Institution: Marsi Bionics S.L.
Hypothesis
The study aims to evaluate the safety and usability of the ATLAS 2030 robotic gait device in children with Cerebral Palsy and Spinal Muscular Atrophy.
Conclusion
The ATLAS 2030 was shown to be safe for children with CP and SMA, with good usability and high satisfaction reported by both children and therapists.
Supporting Evidence
- No serious adverse events were reported during the study.
- Participants showed an increase in the average cadence and number of steps per session.
- Satisfaction was considered high by both children and therapists.
- The mean donning time decreased significantly by the end of the study.
- Children with CP increased the distance walked in the 6MWT by 2.0 m.
- Children with SMA increased the distance walked in the 6MWT by 3.1 m.
Takeaway
The ATLAS 2030 robotic device helps kids with walking problems feel safe and happy while using it, and it works well for them.
Methodology
The study involved six children who received eight sessions of robot-assisted gait therapy, measuring safety through adverse events and usability through various performance metrics.
Limitations
The sample size was small, and the number of sessions may not fully capture the device's benefits.
Participant Demographics
Participants included three children with Cerebral Palsy and three with Spinal Muscular Atrophy, aged between 3 to 14 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website